Chronic kidney disease is a silent killer that costs Medicare over $120 billion dollars annually. The 80 million Americans at risk of developing the disease are still mostly unaware of the threat—and are at a heightened risk from COVID-19 as well. Allowing them to test from the safety of home with their smartphone can help save lives and cut healthcare costs.
As the COVID-19 pandemic continues to rage, there is a real risk that CKD, like other chronic conditions, will be neglected, contributing to the ballooning cost of care and loss of life.
To help prevent the next generation of people with CKD from ever reaching the point where they require kidney replacement or dialysis, screening for the disease early and safely is key.
Tackling CKD with Early Detection
Raising Compliance with At-Home Testing
Healthy.io’s CKD Early-Detection Service allows people to do their ACR urine test from the comfort of their homes using a test kit and their smartphone, saving them a visit to the clinic. The service uses proprietary artificial intelligence algorithms to recognize the dipstick’s true colors, regardless of the wide variance in smartphone camera type and lighting conditions. As part of the service, people also receive a friendly reminder to do the test if they have not yet done so.